Primary Hyperoxaluria in Korean Pediatric Patients
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Primary hyperoxaluria (PH), a rare inborn error of glyoxylate meta bolism causing overproduction of oxalate, is classified into three genetic subgroups: type 1–3 (PH1–PH3) caused by AGXT, GRHPR , and HOGA1 gene mutations, respectively. We performed a retrospective case series study of Korean pediatric patients with PH. Methods: In total, 11 unrelated pediatric patients were recruited and their phenotypes and genotypes were analyzed by a retrospective review of their medical records. Results: Mutational analyses revealed biallelic AGXT mutations (PH1) in nine patients and a single heterozygous GRHPR and HOGA1 mutation in one patient each. The c.33dupC was the most common AGXT mutation with an allelic frequency of 44%. The median age of onset was 3 months (range, 2 months–3 years), and eight patients with PH1 presented with end stage renal disease (ESRD). Patients with two truncating mutations showed an earlier age of onset and more frequent retinal involvement than patients with one truncating mutation. Among eight PH1 patients presenting with ESRD, five patients were treated with intensive dialysis followed by liver transplantation (n=5) with/without subsequent kidney transplantation (n=3). Conclusion: Most patients presented with severe infantile forms of PH. Patients with two truncating mutations displayed more severe phenotypes than those of patients with one truncating mutation. Sequential liver and kidney transplantation was adopted for PH1 patients presenting with ESRD. A larger nation-wide multicenter study is needed to confirm the genotype-phenotype correlations and outcomes of organ transplantation.
Abstract
Background: Primary hyperoxaluria (PH), a rare inborn error of glyoxylate meta bolism causing overproduction of oxalate, is classified into three genetic subgroups: type 1–3 (PH1–PH3) caused by AGXT, GRHPR , and HOGA1 gene mutations, respectively. We performed a retrospective case series study of Korean pediatric patients with PH. Methods: In total, 11 unrelated pediatric patients were recruited and their phenotypes and genotypes were analyzed by a retrospective review of their medical records. Results: Mutational analyses revealed biallelic AGXT mutations (PH1) in nine patients and a single heterozygous GRHPR and HOGA1 mutation in one patient each. The c.33dupC was the most common AGXT mutation with an allelic frequency of 44%. The median age of onset was 3 months (range, 2 months–3 years), and eight patients with PH1 presented with end stage renal disease (ESRD). Patients with two truncating mutations showed an earlier age of onset and more frequent retinal involvement than patients with one truncating mutation. Among eight PH1 patients presenting with ESRD, five patients were treated with intensive dialysis followed by liver transplantation (n=5) with/without subsequent kidney transplantation (n=3). Conclusion: Most patients presented with severe infantile forms of PH. Patients with two truncating mutations displayed more severe phenotypes than those of patients with one truncating mutation. Sequential liver and kidney transplantation was adopted for PH1 patients presenting with ESRD. A larger nation-wide multicenter study is needed to confirm the genotype-phenotype correlations and outcomes of organ transplantation.
참고문헌 (30)
- Cochat P, "Primary hyperoxaluria", N Engl J Med, 369, pp.649~658 (2013)
- Purdue PE, "Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine", glyoxylate aminotransferase in primary hyperoxaluria type 1, 1990, pp.111(6 Pt 1), 2341~2351
- Cramer SD, "The gene encoding hydroxypyruvate reductase(GRHPR)is mutated in patients with primary hyperoxaluria type II", Hum Mol Genet, 8, pp.2063~2069 (1999)
- Belostotsky R, "Mutations in DHDPSL are responsible for primary hyperoxaluria type III", Am J Hum Genet, 87, pp.392~399 (2010)
- Hoppe B, "An update on primary hyperoxaluria", Nat Rev Nephrol, 8, pp.467~475 (2012)
- Kim HH, "Late-onset primary hyperoxaluria diagnosed after renal transplantation presented with early recurrence of disease", Nephrol Dial Transplant, 20, pp.1738~1740 (2005)
- 김시은, "A rare case of hyperoxaluria presenting with acute liver injury and stone-free kidney injury", Kidney Research and Clinical Practice, 34(2), pp.113~116 (2015), 대한신장학회
- Cochat P, "Epidemiology of primary hyperoxaluria type 1", Nephrol Dial Transplant, 10(Suppl 8), pp.3~7 (1995)
- van Woerden CS, "Primary hyperoxaluria type 1 in the Netherlands : prevalence and outcome", Nephrol Dial Transplant, 18, pp.273~279 (2003)
- Harambat J, "Characteristics and outcomes of children with primary oxalosis requiring renal replacement therapy", Clin J Am Soc Nephrol, 7, pp.458~465 (2012)
- "NAPRTCS 2011 Annual Dialysis Report"[URL]
- Hattori S, "Japanese Society for Pediatric Nephrology. The 1998 report of the Japanese national registry data on pediatric end-stage renal disease patients", Pediatr Nephrol, 17, pp.456~461 (2002)
- Al-Eisa AA, "End-stage renal disease in Kuwaiti children : an 8-year experience", Transplant Proc, 36, pp.1788~1791 (2004)
- Kamoun A, "End-stage renal disease of the Tunisian child : epidemiology, etiologies, and outcome", Pediatr Nephrol, 10, pp.479~482 (1996)
- Williams EL, "Primary hyperoxaluria type 1 : update and additional mutation analysis of the AGXT gene", Hum Mutat, 30, pp.910~917 (2009)
- Hopp K, "Phenotype-genotype correlations and estimated carrier frequencies of primary hyperoxaluria", J Am Soc Nephrol, 26, pp.2559~2570 (2015)
- Monico CG, "Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele", Kidney Int, 67, pp.1704~1709 (2005)
- Harambat J, "Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome", Kidney Int, 77, pp.443~449 (2010)
- van Woerden CS, "Clinical implications of mutation analysis in primary hyperoxaluria type 1", Kidney Int, 66, pp.746~752 (2004)
- Mandrile G, "Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation type", Kidney Int, 86, pp.1197~1204 (2014)
- Rumsby G, "Evaluation of mutation screening as a first line test for the diagnosis of the primary hyperoxalurias", Kidney Int, 66, pp.959~963 (2004)
- Frishberg Y, "Intra-familial clinical heterogeneity : absence of genotype-phenotype correlation in primary hyperoxaluria type 1 in Israel", Am J Nephrol, 25, pp.269~275 (2005)
- Milliner DS, "Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria", N Engl J Med, 331, pp.1553~1558 (1994)
- Hoppe B, "Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure", Kidney Int, 56, pp.268~274 (1999)
- Illies F, "Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1", Kidney Int, 70, pp.1642~1648 (2006)
- Kemper MJ, "Preemptive liver transplantation in primary hyperoxaluria type 1 : timing and preliminary results", J Nephrol, 11(Suppl 1), pp.46~48 (1998)
- Cochat P, "Primary hyperoxaluria type 1 : practical and ethical issues", Pediatr Nephrol, 28, pp.2273~2281 (2013)
- Malla I, "Two-step transplantation for primary hyperoxaluria : cadaveric liver followed by living donor related kidney transplantation", Pediatr Transplant, 13, pp.782~784 (2009)
- Mor E, "Sequential liver and kidney transplantation from a single living donor in two young adults with primary hyperoxaluria type 1", Liver Transpl, 19, pp.646~648 (2013)
- Allard L, "Renal function can be impaired in children with primary hyperoxaluria type 3", Pediatr Nephrol, 30, pp.1807~1813 (2015)